Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease

10 Nov 2017

Abstract excerpt

Moderate to severe chronic graft-versus-host disease (GVHD) is treated with potent immunosuppressive therapy (IST) to modulate the allo-immune response, control symptoms, and prevent further organ damage. We sought to understand the types of treatments used in clinical practice and the likelihood of successful treatment associated with each. A chart review was performed for 250 adult patients at Fred Hutchinson...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Mesenchymal stem cell research
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29133250
DOI: 10.1016/j.bbmt.2017.10.042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseasePMID 29133250Read ↗

Chronic graft-versus-host disease after allogeneic blood stem cell transplantationSemantic proximity Read ↗

Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantationSemantic proximity Read ↗

Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and TreatmentSemantic proximity Read ↗

Graft-versus-host diseaseSemantic proximity Read ↗

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesSemantic proximity Read ↗

Chronic Graft-vs-Host DiseaseSemantic proximity Read ↗

Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic TransplantationSemantic proximity Read ↗

Chronic graft-versus-host diseaseSemantic proximity Read ↗

Chronic graft-versus-host disease: A prospective cohort studySemantic proximity Read ↗

Emerging Therapeutics for the Control of Chronic Graft-versus-Host DiseaseSemantic proximity Read ↗

Evaluating Axatilimab as a treatment option for chronic graft-versus-host diseaseSemantic proximity Read ↗

Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.